128 related articles for article (PubMed ID: 33319888)
1. Design, synthesis and biological evaluation of dihydro-2-quinolone platinum(iv) hybrids as antitumor agents displaying mitochondria injury and DNA damage mechanism.
Liu Z; Li Z; Du T; Chen Y; Wang Q; Li G; Liu M; Zhang N; Li D; Han J
Dalton Trans; 2021 Jan; 50(1):362-375. PubMed ID: 33319888
[TBL] [Abstract][Full Text] [Related]
2. A novel star-shaped trinuclear platinum(II) complex based on a 1,3,5-triazine core displaying potent antiproliferative activity against TNBC by the mitochondrial injury and DNA damage mechanism.
Wu Y; Zhao D; Shang J; Huang W; Chen Z
Dalton Trans; 2022 Jul; 51(29):10930-10942. PubMed ID: 35731536
[TBL] [Abstract][Full Text] [Related]
3. Naproxen platinum(iv) hybrids inhibiting cycloxygenases and matrix metalloproteinases and causing DNA damage: synthesis and biological evaluation as antitumor agents in vitro and in vivo.
Chen Y; Wang Q; Li Z; Liu Z; Zhao Y; Zhang J; Liu M; Wang Z; Li D; Han J
Dalton Trans; 2020 Apr; 49(16):5192-5204. PubMed ID: 32236281
[TBL] [Abstract][Full Text] [Related]
4. A potent aminonaphthalimide platinum(IV) complex with effective antitumor activities in vitro and in vivo displaying dual DNA damage effects on tumor cells.
Wang Q; Chen Y; Li G; Zhao Y; Liu Z; Zhang R; Liu M; Li D; Han J
Bioorg Med Chem Lett; 2019 Oct; 29(20):126670. PubMed ID: 31500997
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, and biological activity of platinum II, III, and IV pivaloamidine complexes.
Sinisi M; Gandin V; Saltarella T; Intini FP; Pacifico C; Marzano C; Natile G
J Biol Inorg Chem; 2014 Oct; 19(7):1081-97. PubMed ID: 24850131
[TBL] [Abstract][Full Text] [Related]
6. Dual-target platinum(IV) complexes exhibit antiproliferative activity through DNA damage and induce ER-stress-mediated apoptosis in A549 cells.
Wang M; Liu Z; Huang X; Chen Y; Wang Y; Kong J; Yang Y; Yu C; Li J; Wang X; Wang H
Bioorg Chem; 2021 May; 110():104741. PubMed ID: 33647739
[TBL] [Abstract][Full Text] [Related]
7. Multi-specific niflumic acid platinum(IV) complexes displaying potent antitumor activities by improving immunity and suppressing angiogenesis besides causing DNA damage.
Li L; Zhang M; Jia D; Liu Z; Zhang N; Sun B; Wang Z; Liu M; Wang Q
Dalton Trans; 2022 Dec; 52(1):147-158. PubMed ID: 36472127
[TBL] [Abstract][Full Text] [Related]
8. A novel synthetic protoapigenone analogue, WYC02-9, induces DNA damage and apoptosis in DU145 prostate cancer cells through generation of reactive oxygen species.
Chen HM; Chang FR; Hsieh YC; Cheng YJ; Hsieh KC; Tsai LM; Lin AS; Wu YC; Yuan SS
Free Radic Biol Med; 2011 May; 50(9):1151-62. PubMed ID: 21256211
[TBL] [Abstract][Full Text] [Related]
9. Effect of dicycloplatin, a novel platinum chemotherapeutical drug, on inhibiting cell growth and inducing cell apoptosis.
Li GQ; Chen XG; Wu XP; Xie JD; Liang YJ; Zhao XQ; Chen WQ; Fu LW
PLoS One; 2012; 7(11):e48994. PubMed ID: 23152837
[TBL] [Abstract][Full Text] [Related]
10. Novel tacrine platinum(II) complexes display high anticancer activity via inhibition of telomerase activity, dysfunction of mitochondria, and activation of the p53 signaling pathway.
Qin QP; Wang SL; Tan MX; Wang ZF; Luo DM; Zou BQ; Liu YC; Yao PF; Liang H
Eur J Med Chem; 2018 Oct; 158():106-122. PubMed ID: 30205260
[TBL] [Abstract][Full Text] [Related]
11. Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions.
Savino S; Marzano C; Gandin V; Hoeschele JD; Natile G; Margiotta N
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011897
[TBL] [Abstract][Full Text] [Related]
12. Enhancing Cytotoxicity of a Monofunctional Platinum Complex via a Dual-DNA-Damage Approach.
Guo Y; He Y; Wu S; Zhang S; Song D; Zhu Z; Guo Z; Wang X
Inorg Chem; 2019 Oct; 58(19):13150-13160. PubMed ID: 31539237
[TBL] [Abstract][Full Text] [Related]
13. Oxidative DNA double strand breaks and autophagy in the antitumor effect of sterically hindered platinum(II) complexes in NSCLCs.
Chen F; Wang X; Jin X; Zhao J; Gou S
Oncotarget; 2017 May; 8(19):30933-30955. PubMed ID: 28427237
[TBL] [Abstract][Full Text] [Related]
14. Glycyrrhetinic Acid as a Hepatocyte Targeting Ligand-Functionalized Platinum(IV) Complexes for Hepatocellular Carcinoma Therapy and Overcoming Multidrug Resistance.
Huang X; Li G; Li H; Zhong W; Jiang G; Cai J; Xiong Q; Wu C; Su K; Huang R; Xu S; Liu Z; Wang M; Wang H
J Med Chem; 2024 May; 67(10):8020-8042. PubMed ID: 38727048
[TBL] [Abstract][Full Text] [Related]
15. Assessing Impact of Platinum Complexes on Mitochondrial Functions.
Jin S; Wang X
Methods Mol Biol; 2021; 2276():409-423. PubMed ID: 34060058
[TBL] [Abstract][Full Text] [Related]
16. Antitumor and cellular pharmacological properties of a novel platinum(IV) complex: trans-[PtCl(2)(OH)(2)(dimethylamine) (isopropylamine)].
Pérez JM; Kelland LR; Montero EI; Boxall FE; Fuertes MA; Alonso C; Navarro-Ranninger C
Mol Pharmacol; 2003 Apr; 63(4):933-44. PubMed ID: 12644595
[TBL] [Abstract][Full Text] [Related]
17. Development of a series of 4-hydroxycoumarin platinum(IV) hybrids as antitumor agents: Synthesis, biological evaluation and action mechanism investigation.
Li G; Zhang J; Liu Z; Wang Q; Chen Y; Liu M; Li D; Han J; Wang B
J Inorg Biochem; 2019 May; 194():34-43. PubMed ID: 30826588
[TBL] [Abstract][Full Text] [Related]
18. A dual-targeting, p53-independent, apoptosis-inducing platinum(II) anticancer complex, [Pt(BDI(QQ))]Cl.
Suntharalingam K; Wilson JJ; Lin W; Lippard SJ
Metallomics; 2014 Mar; 6(3):437-43. PubMed ID: 24514456
[TBL] [Abstract][Full Text] [Related]
19. Antitumor platinum(II) complexes containing platinum-based moieties of present platinum drugs and furoxan groups as nitric oxide donors: synthesis, DNA interaction, and cytotoxicity.
Zhao J; Gou S; Sun Y; Fang L; Wang Z
Inorg Chem; 2012 Oct; 51(19):10317-24. PubMed ID: 22957695
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms by which the antitumor compound di-n-butyl-di-(4-chlorobenzohydroxamato)tin(IV) induces apoptosis and the mitochondrial-mediated signaling pathway in human cancer SGC-7901 cells.
Li Y; Liu J; Li Q
Mol Carcinog; 2010 Jun; 49(6):566-81. PubMed ID: 20336762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
